Garg Pushkal Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
18
Insider Sells Sum
$26.99M

Insider Activity of Garg Pushkal

According to the SEC Form 4 filings, Garg Pushkal, being in a position of

  1. EVP Chief R&D at Alnylam Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 19070 shares for $6.33M,
    over all time since 2023-03-03, has bought 0 shares, and sold 135096 shares for $37.7M.

Biography of Garg Pushkal

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $6,329,5039100

Comparison of Insiders on Amount of Buys and Sells

2026-03-05SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP Chief R&D
2,404
0.0018%
$323.96$778,812-10.71%
2026-03-04SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP Chief R&D
2,309
0.0017%
$323.08$745,984-12.54%
2026-03-03SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP Chief R&D
1,775
0.0013%
$319.74$567,546-10.14%
2026-03-02SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP Chief R&D
1,717
0.0013%
$327.66$562,585-11.89%
2026-02-27SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP Chief R&D
4,627
0.0035%
$331.34$1.53M-13.94%
2026-02-13SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP Chief R&D
2,242
0.0017%
$310.08$695,201-8.34%
2026-01-12SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP Chief R&D
1,510
0.0011%
$362.87$547,929-20.79%
2026-01-12SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP Chief R&D
1,268
0.0009%
$361.46$458,333-20.79%
2026-01-12SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP Chief R&D
1,218
0.0009%
$361.26$440,013-20.79%
2025-10-03SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP Chief R&D
3,022
0.0023%
$451.48$1.36M-30.47%
2025-10-02SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP Chief R&D
2,937
0.0022%
$452.05$1.33M-31.16%
2025-08-19SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP Chief R&D
1,455
0.0011%
$458.41$666,987-27.72%
2025-08-19SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP Chief R&D
845
0.0006%
$456.93$386,107-27.72%
2025-08-18SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP Chief R&D
1,396
0.0011%
$453.27$632,759-27.2%
2025-03-24SaleAlnylam Pharmaceuticals, Inc.
ALNY
CMO & EVP Dev & Med Affairs
5,445
0.0043%
$300.00$1.63M+21.02%
2025-03-21SaleAlnylam Pharmaceuticals, Inc.
ALNY
CMO & EVP Dev & Med Affairs
4,321
0.0033%
$285.00$1.23M+24.19%
2025-03-04SaleAlnylam Pharmaceuticals, Inc.
ALNY
CMO & EVP Dev & Med Affairs
808
0.0006%
$241.05$194,766+44.82%
2025-03-03SaleAlnylam Pharmaceuticals, Inc.
ALNY
CMO & EVP Dev & Med Affairs
1,749
0.0014%
$243.79$426,384+44.46%
2025-02-28SaleAlnylam Pharmaceuticals, Inc.
ALNY
CMO & EVP Dev & Med Affairs
935
0.0007%
$241.69$225,977+42.61%
2025-02-18SaleAlnylam Pharmaceuticals, Inc.
ALNY
CMO & EVP Dev & Med Affairs
1,548
0.0012%
$251.67$389,579+40.72%
Total: 32
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.